Peripheral Nerve Stimulation

Published on 24/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2270 times

Chapter 18 Peripheral Nerve Stimulation

Percutaneous Technique

Chapter Overview

Chapter Synopsis: Peripheral nerve stimulation (PNS) directly stimulates peripheral nerves for the treatment of various indications of neuropathic pain. Although the stimulating electrode is usually implanted directly in an open surgical technique, leads can also be implanted percutaneously in a less-invasive procedure that avoids open dissection of the nerve itself. Ultrasound imaging can provide guidance in placement of the electrodes. This technique has some advantages over open surgical implantation, including reduced risk of potential nerve trauma during dissection. Percutaneous implantation also avoids the need for an insulating fascial transplant between the electrode and the nerve because the epineural fat is preserved. Further, a percutaneous trial can identify inappropriate subjects, avoiding unnecessary surgical implants that might fail. The data supporting success of PNS as a treatment for neuropathic pain are somewhat limited, mainly because of experimental confounds inherent in the technique, but they clearly show that PNS can provide pain relief. Anatomical and fascicular details should be considered in advance of percutaneous electrode implantation. As in any neurostimulatory technique, proper patient selection is key to successful treatment, and steps should be taken to prevent migration of the implanted lead.

Important Points:

Clinical Pearls:

Clinical Pitfalls:

Introduction

Peripheral nerve stimulation (PNS) is a technique of direct electrical stimulation of peripheral nerve(s) to relieve pain or to assist with the functional restoration of patients with severe neurological injuries, including those to the spinal cord. The term PNS has also been used to describe the superficial placement of electrical leads in areas of the body such as the back, thorax, or abdomen where no discrete named nerves exist but small nerve fibers near the dermis can be targeted to produce local analgesia. This type of stimulation is mechanistically poorly understood and will be referred to as peripheral field stimulation (not the subject of this chapter). PNS became conceptually possible after the development of the gate control theory.1 Wall and Sweet’s experiments with PNS tested the concept of electrical stimulation–produced analgesia, initially of the authors’ infraorbital nerves and subsequently in eight patients.2 Soon many neurological and orthopedic surgeons became interested in the technique, and several case series of these peripheral nerve surgeries were described 36 The early history of the development of these techniques is chronicled by Michael Stanton-Hicks and colleagues,6 who describe the indications, outcomes, and complications of a series of 91 patients at the Cleveland Clinic. Despite early investigator interest and the development of novel lead and battery technology, innovations in programmability, and other technical improvements for stimulation of the peripheral nerves, the application and study of PNS has been less vigorous in scope than that for spinal cord stimulation. The absence of a comparable minimally invasive trial system that became available with the introduction of percutaneous spinal cord stimulation electrodes in the 1980s may be one reason that peripheral nerve surgeries have not advanced as rapidly. Other potential reasons for decreased interest in PNS may be frequent complications such as lead migration (requiring revision surgery), neurological damage to the axons from mechanical or stimulation-induced nerve injury, and poor patient selection leading to poor outcomes. PNS has always been an open technique since its inception more than 40 years ago, but recently minimally invasive techniques were described.79 Possible advantages to peripheral nerve stimulator placement via a minimally invasive technique might include: (1) minimal nerve trunk dissection and manipulation (potential trauma); (2) the omission of the need for a fascial graft or fat pad interposed between the electrode and the nerve (the fat around the epineurium in situ is minimally perturbed by the percutaneous electrode); (3) a true percutaneous trial avoiding dissection and open surgery; and (4) the ability to perform intraoperative electrical stimulation testing in an awake patient with minimal sedation compared to a patient under general anesthesia. Cadaver feasibility studies were performed in 2008,7,8 suggesting that ultrasound (US) image guidance might allow safe placement of peripheral nerve stimulating electrodes near target peripheral nerves, similar to nerve catheter placement. Following these feasibility studies, a case series of nine patients who received PNS placements using US was published, based on the principles described in the cadaver studies.9 In two of the nine cases, patients with good paresthesia coverage did not achieve analgesia and were not implanted, thus avoiding an unnecessary surgical dissection. Most cases produced durable analgesia beyond 1 year. The programming of multiple different stimulation parameters intraoperatively allowed the additional placement of second electrodes parallel to the first or on either side of a nerve trunk to more optimally stimulate the desired fascicles in some cases (Fig. 18-1).9 Others have described a stimulus router concept that eliminates the need for an implanted generator. A surgeon places a passive implant delivery terminal near the target nerve. Current is passed between a surface cathodal electrode and a pick-up terminal, a small fraction of which (10% to15%) is passed to the delivery terminal. This results in PNS at threshold. It is unclear at this time if this type of implant would be less prone to migration without additional study (Fig. 18-2).10

Currently the only commercial U.S. Food and Drug Administration (FDA)–approved electrodes for PNS are four-contact flat paddle arrays, which must be placed via an open surgical dissection, often with an interposed fascial graft, which is thought to protect the nerve. Neurological surgeons usually place the electrodes longitudinally to maximize the number of contacts in direct apposition to the nerve. Since ideal electrode availability and long-term safety testing is minimal, neurosurgical open procedures with the paddle electrodes are likely to remain the preferred method of placement of these devices in the near term. Whether the use of percutaneous techniques might allow future patients to undergo trial placements without significant investment in an open procedure or whether percutaneous permanent placements will become a reality will depend on the pace of new electrode design, future studies of PNS outcomes, and FDA approval of novel leads or other devices.

Current Evidence

At this juncture no prospective randomized and blinded studies have been performed. A recent paper by Bittar and Teddy11 reviewed the current evidence for PNS. Unfortunately the greatest need for evidence at this time is from prospective, randomized controlled, and blinded studies. Until now these studies have been difficult if not impossible to perform because of patient perception of a physical sensation (paresthesia), which hampers blinding, and the lack of minimally invasive, ethical controls. In an editorial on the subject of peripheral neuromodulation, Davis12 discussed some of the factors that may make interpretation of currently available studies difficult. Questions regarding the role of external neurolysis (the removal of external scarring around the nerve) on the analgesia seen after PNS, unclear placebo effects, the unequal application of physical therapy in some patient groups, lack of standardization of potentially analgesic drugs (including neuromodulators and opioids), or the increased attention to the patient needs during study protocols are all possible confounding factors. Long-term studies are difficult, but some studies seem to suggest an extremely long-standing effect of PNS, with the possibility of nerve healing over time.13 Van Calenbergh and colleagues13 looked back at a group of 11 patients who had been chronically implanted with radiofrequency-coupled peripheral nerve stimulators over an average period of 22 years! Of these 11, four had been explanted, one had died of unrelated causes to his or her stimulator, and one could not participate because of distance from the study center. The remaining five patients had long-term circumferential electrode arrays. These patients demonstrated a durable improvement in their pain, level of function, and use of analgesics when comparing stimulation off to stimulation on. They had sustained minimal complications. Remarkably, benefits persisted despite the passage of over two decades on average. One patient had even demonstrated gradual resolution of his neuropathic pain in the face of neural stimulation. The largest clinical series in print to date are those from Eisenberg, Waisbrod, and Gerbershagen14 and the Cleveland Clinic.6 In Eisenberg, Waisbrod, and Gerbershagen’s series, 46 patients with isolated peripheral nerve syndromes were treated. Positive results were noted in 78% of patients, whereas 22% had poor results. Decreases in visual analog pain scores from 69 ± 12 before surgery to 24 ± 28 after surgery were seen.12 The major pathologies treated in the PNS protocols were for the following: (1) nerve lesions incurred from surgeries around the hip or knee, (2) nerve entrapments, (3) persistent pain after nerve graft surgeries, or (4) postaccidental nerve injection injuries.14 In the previously unpublished Cleveland Clinic series,6 results on average were positive, with a frequency of revision surgery of 1.6 per patient, not including battery replacements.

Patient Selection

In general patients with neuropathic pain syndromes involving the periphery may qualify for these procedures when they have failed to improve with more conventional and conservative therapies. Patients should be evaluated thoroughly, with the medical history concentrating on previous diagnostic studies, previous failed medication trials, any previous surgical procedures, electrodiagnostic results, and results of any previous nerve block procedures. In the physical examination the physician should concentrate on the neurological, musculoskeletal, and skin examinations. Presence of any motor deficits, sensory deficits, specific dermatomal or peripheral nerve distributions, presence or absence of allodynia, hyperesthesia, hypesthesia, or hyperalgesia should be noted. Vasomotor, sudomotor, or trophic changes should be noted since they may point to a complex regional pain syndrome. Electrodiagnostic studies are extremely important but may be normal in primary pain syndromes. Electromyography (EMG) and nerve conduction studies (NCSs) are also important to the classification, grading, and prognostication of many injuries. In some cases serial evaluations of patients with EMG/NCS can show important trends in reinnervation or ongoing denervation of specific areas. Nerve blocks are an important modality in preoperative patient selection as well. Blocking the suspected nerve proximal to the site of injury helps confirm the involvement of that nerve in the pathophysiology of the pain. One protocol has evolved with the use of local anesthetic coupled with clonidine (Catapres) for neural blockade. In addition to its ability to prolong the effects of the local anesthetic in many cases, clonidine may be important in the inflammatory pain response by blocking production of cytokines involved in hyperalgesia. Indeed, Lavand’homme and Eisenbach15 have demonstrated prolonged relief of some neuropathic pain states with clonidine. Whether the nerve block is performed with US or electrical stimulation and surface landmarks is perhaps not of paramount importance. However, one advantage of US guidance is the ability to fully scan the patient’s area of interest. In some cases one might diagnose a specific underlying cause such as a neuroma (Fig. 18-3), a constriction caused by mechanical factors, a foreign body, or an anatomical variant that might pose problems with the technique. Other imaging modalities such as magnetic resonance studies are increasingly sophisticated and capable of influencing treatment decisions.

Safety

It seems intuitively obvious that objects placed in close proximity to a peripheral nerve or abutting against the nerve might potentially cause neural injury. Indeed, previous studies have demonstrated the possibility of neural damage from the surgical procedure itself but also from friction on the epineurium by normal nerve movement (translocation) in an extremity. There have been only minimal studies with respect to a purely mechanical effect. Agnew and colleagues16 have studied the effects of perineurial electrodes relative to both mechanical and stimulation effects on nerve function long term. These studies were done with helical electrode arrays with three to seven circumferential twists. In one experiment a control side was used to evaluate whether the mechanical or stimulation effects were responsible for adverse changes in histology. Prolonged stimulation with higher frequencies and continuous application of bipolar current have both been shown to cause neurological injury. Interestingly the use of local anesthetics seems to be protective against the development of peripheral nerve injuries from the stimulation.17 The local anesthetic protective effect suggests that the conduction of long-term high-frequency electrical charge is causative for global axonal changes seen in histological specimens. Other studies of long-term application of stimulation to the other nerves (e.g., phrenic nerves) have shown inconsistent effects. Although significant changes were noted in some, many patients had no histological changes.18 However, since the phrenic is a motor nerve, any major axonal injury might be more clinically evident. In the initial case series of PNS patients with US-guided placements, stimulation frequencies have been low. Subthreshold stimulation (amplitudes below the perception of a physical paresthesia) at frequencies below 100 Hz and with more narrow pulse widths was frequently used.9 There were no episodes of neural injury caused by US-guided PNS, despite three episodes of lead migration. In addition, there is a long history of PNS implant surgery over the last four decades, with rare reports of permanent nerve damage from the stimulation implant.

Anatomical Considerations: Nerve Fascicular Arrangement

One issue that complicates any peripheral nerve electrode placement in the four extremities is that nerves must freely glide within fascial/muscle planes along with their vascular supply as the extremity moves. Nerves can be entrapped by scar tissue, and the rough edges of an external electrode could cause constriction and scarring over time. Mixed peripheral nerves are also characterized by a complex internal fascicular arrangement. Briefly, nerve trunks may have sensory, motor, and mixed axons at various locations within the peripheral nerve. This complex cross-sectional anatomical configuration means that optimal stimulation of the desired sensory fascicle might, for example, be at the medial aspect of the ulnar nerve in a supracondylar placement but change location within a matter of a few millimeters to a posterior location. If the amplitude of stimulation is too high above sensory threshold, motor fascicles deeper within the trunk may easily be activated, causing muscle cramping and/or pain. Sunderlund19 studied the complex fascicular arrangements in the upper-extremity nerves more than 60 years ago. Very little additional work has been done on this topic. Major findings from his work are that even intraindividual (side-to-side) differences, branch points, and number of fascicles at a given anatomical location may vary. Thus stimulation intraoperatively could be useful to determine the potential for good-to-excellent results of PNS. A recent study looked at issues of cross-sectional anatomy more closely; specifically the effects of the fascicle perineurial thickness, diameter, and position within the nerve trunk on axonal excitation thresholds and neural recruitment. A model of human femoral nerve within a nerve circumferential cuff electrode was studied. The study showed that stimulation of target fascicles depends strongly on the cross-sectional anatomy of the nerve being stimulated. The mean thickness of perineurium was 3% ± 1% of the fascicle diameter. Increased thickness of the human perineurium or larger fascicle diameter increases the threshold for electrical activation. If a large neighbor fascicle were present, it could also affect stimulation activation of the target fascicle by as much as 80% ± 11%.20

Common Approaches to Ultrasound-Guided Peripheral Nerve Stimulation

Posterior Tibial Nerve Stimulation

The posterior tibial nerve can stimulated more distally in the leg superior to the medial malleolus. The tarsal tunnel is a common area of potential compression; however, the tissue immediately superior to the tarsal tunnel is very compact and not easily approached with a US-guided approach. Moving a bit more superior to the malleolus (e.g., 10 to 14 cm superior) was found to be a reasonable approach in feasibility testing.8 The tibialis posterior muscle, the digitorum profundus, one or two large veins, the flexor hallucis longus, and the tibial bone surface are surrounding structures in this location (Fig. 18-5). US scanning of the ankle near the medial malleolus, with transverse probe orientation, is continued proximally until an adequate exposure of the nerve is realized. Location of the posterior tibial artery is often not an obstacle but should be noted during electrode placement. When approaching the posterior tibial nerve in the lower leg, the needles may be passed on either side to “sandwich” the nerve, providing stimulation of both sides; or, conversely, the electrodes may be placed parallel to each other if two leads are required (Fig. 18-6). The pulse generator may be placed in the upper leg, superficial to the fascia of the quadriceps, or on the fascia of medial gastrocnemius muscle in the lower leg if adequate soft tissue is noted.

References

1 Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.

2 Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155:108-109.

3 Nashold BS, et al. Long-term pain control by direct peripheral nerve stimulation. J Bone Joint Surg Am. 1982;64:1-10.

4 Strege DW, et al. Chronic peripheral nerve pain treated with direct electrical nerve stimulation. J Hand Surg (Am). 1994;19:931.

5 Hassenbusch SJ, et al. Long-term results of peripheral nerve stimulation for reflex sympathetic dystrophy. J Neurosurg. 1996;84:415-423.

6 Stanton-Hicks M, et al. Miscellaneous and experimental therapies. In: Wilson PR, Stanton-Hicks M, Harden R, editors. CRPS: Current diagnosis and therapy, progress in pain research and management, vol. 32. Seattle: IASP Press; 2005.

7 Huntoon MA, et al. Feasibility of ultrasound guided percutaneous placement of peripheral nerve stimulation electrodes and anchoring during simulated movement. Part Two: Upper extremity. Reg Anesth Pain Med. 2008;33:558-565.

8 Huntoon MA, et al. Feasibility of ultrasound guided percutaneous placement of peripheral nerve stimulation electrodes in a cadaver model. Part One: Lower extremity. Reg Anesth Pain Med. 2008;33:551-557.

9 Huntoon MA, Burgher AH. Ultrasound-guided permanent implantation of peripheral nerve stimulation (PNS) system for neuropathic pain of the extremities: original cases and outcomes. Pain Med. 2009;10:1369-1377.

10 Gan LS, et al. A new means of transcutaneous coupling for neural prostheses. IEEE Transact Biomed Engin. 2007;54:509-517.

11 Bittar RG, Teddy PJ. Peripheral neuromodulation for pain. J Clin Neurosci. 2009:1259-1261.

12 Davis GA. Commentary: peripheral neuromodulation for pain. J Clin Neurosci. 2009;16:1262.

13 Van Calenbergh F, et al. Long-term clinical outcome of peripheral nerve stimulation in patients with chronic peripheral neuropathic pain. Surg Neurol. 2009;72:330-335.

14 Eisenberg E, Waisbrod H, Gerbershagen HU. Long- term peripheral nerve stimulation for painful nerve injuries. Clin J Pain. 2004;20:143-146.

15 Lavand’homme P, Eisenach JC. Perioperative administration of the alpha-2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression. Pain. 2003;105:247-254.

16 Agnew WF, et al. Histologic and physiologic evaluation of electrically stimulated peripheral nerve: considerations for the selection parameters. Ann Biomed Engin. 1989;17:39-60.

17 Agnew WF, et al. Local anesthetic protects against electrically induced damage in peripheral nerve. J Biomed Engin. 1990;12:301-308.

18 Kim JH, et al. Diaphragm-pacing histopathological changes in the phrenic nerve following long-term electrical stimulation. J Thoracic Cardiovasc Surg. 1976;72:602-608.

19 Sunderland S. The intraneural topography of the radial, median, and ulnar nerves. Brain. 1945;68:243-298.

20 Grinberg Y, et al. Fascicular perineurium thickness, size, and position affect model predictions of neural excitation. IEEE Transact Neural Syst Rehabil Engin. 2008;16:572-581.